Lung Cancer Research Foundation Announces New Research Collaboration with AstraZeneca

By PR Newswire14 days ago

NEW YORK, Feb. 23, 2021 /PRNewswire/ -- The Lung Cancer Research Foundation (LCRF) today announced a collaboration with AstraZeneca to fund over $900,000 in research grants focused on understanding resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs) and...

Continue read on prnewswire.com